Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-03 · accession 0001219036-21-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-05 | 2021-08-03+ | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $25.99 | +100.0K | 260.4K | +62% | +$2.60M |
| DM | 2021-08-05 | 2021-08-03+ | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $34.68 | -100.0K | 232.6K | -30% | -$3.47M |
| DM | 2021-08-05 | 2021-08-03+ | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $0.00 | -100.0K | 120.0K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | M | A | 16,225 | $26.49 | 248,775 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-03 | S | D | 4,170 | $34.00 | 232,550 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-04 | M | A | 38,225 | $27.07 | 270,775 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-04 | S | D | 38,225 | $35.24 | 232,550 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.09 to $35.51, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2021-08-04 | M | A | 11,775 | $27.07 | 244,325 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-04 | S | D | 11,775 | $35.57 | 232,550 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.57 to $35.58, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2021-08-03 | M | A | 4,170 | $23.98 | 236,720 | D | — | — | |
| 8 | Common | Common Stock | 2021-08-03 | S | D | 16,225 | $33.99 | 232,550 | D | — | — | |
| 9 | Common | Common Stock | 2021-08-03 | M | A | 1,775 | $27.07 | 234,325 | D | — | — | |
| 10 | Common | Common Stock | 2021-08-03 | S | D | 1,775 | $35.07 | 232,550 | D | — | — | |
| 11 | Common | Common Stock | 2021-08-03 | M | A | 27,830 | $23.98 | 260,380 | D | — | — | |
| 12 | Common | Common Stock | 2021-08-03 | S | D | 27,830 | $34.00 | 232,550 | D | — | — | |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-03 | M | D | 16,225 | $0.00 | 0 | D | $26.49 · — to 2021-09-17 | 16,225 Common Stock | (F4) The shares subject to this option are fully vested and exercisable. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-03 | M | D | 1,775 | $0.00 | 158,225 | D | $27.07 · — to 2022-09-12 | 1,775 Common Stock | (F4) The shares subject to this option are fully vested and exercisable. |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-04 | M | D | 11,775 | $0.00 | 108,225 | D | $27.07 · — to 2022-09-12 | 11,775 Common Stock | (F4) The shares subject to this option are fully vested and exercisable. |
| 16 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-03 | M | D | 27,830 | $0.00 | 0 | D | $23.98 · — to 2022-03-07 | 27,830 Common Stock | (F4) The shares subject to this option are fully vested and exercisable. |
| 17 | Derivative | Incentive Stock Option (right to buy) | 2021-08-03 | M | D | 4,170 | $0.00 | 0 | D | $23.98 · — to 2022-03-07 | 4,170 Common Stock | (F4) The shares subject to this option are fully vested and exercisable. |
| 18 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-04 | M | D | 38,225 | $0.00 | 120,000 | D | $27.07 · — to 2022-09-12 | 38,225 Common Stock | (F4) The shares subject to this option are fully vested and exercisable. |